| 10301324 |
Ataxia telengiectasia and rad3-related (ATR) inhibitors and methods of their use |
Henry J. Breslin, Oren Gilad, Eric J. Brown, Laura Butler |
2019-05-28 |
|
| 6610854 |
Substituted condensation products of N-benzyl-3-indenylacentamides with heterocyclic aldehydes for neoplasia |
Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu |
2003-08-26 |
|
| 6486158 |
[4,5]-fused-3,6-disubstituted-pyridazines with sulfur-containing substituents in position three for the treatment of neoplasia |
Xiaojing Wang, Paul Gross, Rifat Pamukcu, Gary A. Piazza |
2002-11-26 |
$294,000 |
| 6455703 |
1,3,6,-Trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia |
Rifat Pamukcu |
2002-09-24 |
$533,000 |
| 6426349 |
Substituted condensation products of N-benzyl-3-indenylacetamides with heterocyclic aldehydes for neoplasia |
Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukeu |
2002-07-30 |
$686,000 |
| 6420410 |
Method for treating neoplasia by exposure to N,N′-substituted benzimidazol-2-ones |
Ulrich Ixkes, Rifat Pamukcu, Gary A. Piazza |
2002-07-16 |
$860,000 |
| 6403831 |
Substituted benzylidene indenyl formamides, acetamides and propionamides |
Paul Gross, Klaus Brendel, Rifat Pamukcu, Gary A. Piazza |
2002-06-11 |
$1,343,000 |
| 6348032 |
Method of inhibiting neoplastic cells with benzimidazole derivatives |
Rifat Pamukcu, Ulrich Ixkes, Gary A. Piazza |
2002-02-19 |
$3,244,000 |
| 6300346 |
Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions |
Paul Gross, Klaus Brendel, Rifat Pamukcu, Gary A. Piazza |
2001-10-09 |
$3,168,000 |
| 6211177 |
Method for treating neoplasia by exposure to substituted 2-aryl-benzimidazole derivatives |
Ulrich Ixkes, Rifat Pamukcu, Gary A. Piazza |
2001-04-03 |
$1,959,000 |
| 6180629 |
[4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia |
Xiaojing Wang, Paul Gross, Rifat Pamukcu, Gary A. Piazza |
2001-01-30 |
$7,152,000 |
| 6166053 |
Substituted condensation products of N-benzyl-3-idenylacetamides with heterocyclic aldehydes for neoplasia |
Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu |
2000-12-26 |
$3,952,000 |
| 6160003 |
1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia |
Rifat Pamukcu |
2000-12-12 |
$5,325,000 |
| 6121321 |
Substituted methoxy benzylidene indenyl acetic and propionic acids for treating patients with precancerous lesions |
Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu |
2000-09-19 |
$21,453,000 |
| 6071934 |
Indenyl hydroxamic acids, (hydroxy) ureas and urethanes for treating patients with precancerous lesions |
Paul Gross, Rifat Pamukcu, Klaus Brendel, Gary A. Piazza |
2000-06-06 |
$17,188,000 |
| 6066634 |
Substituted condensation products of N-benzyl-3-indenylacetamides heterocyclic aldehydes for neoplasia |
Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu |
2000-05-23 |
$17,875,000 |
| 6063818 |
Substituted benzylidene indenyl formamides, acetamides and propionamides |
Paul Gross, Klaus Brendel, Rifat Pamukcu, Gary A. Piazza |
2000-05-16 |
$20,612,000 |
| 6028116 |
Substituted condensation products of 1H-indenyl-hydroxyalkanes with aldehydes for neoplasia |
Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu |
2000-02-22 |
$34,311,000 |
| 6020379 |
Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia |
— |
2000-02-01 |
$21,213,000 |
| 5998477 |
Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions |
Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu |
1999-12-07 |
$7,076,000 |
| 5965619 |
Method for treating patients having precancerous lesions with substituted indene derivatives |
Rifat Pamukcu, Gary A. Piazza, Paul Gross, Klaus Brendel |
1999-10-12 |
$6,840,000 |
| 5948779 |
Substituted condensation products of n-benzyl-3-indenyl acetamides with heterocyclic aldehydes |
Paul Gross, Klaus Brendel, Gary A. Piazza, Rifat Pamukcu |
1999-09-07 |
$3,858,000 |
| 5939417 |
1,3,6-trihydro-6-aza-3-oxapentalen-2-one derivatives for the treatment of neoplasia |
Rifat Pamukcu |
1999-08-17 |
$8,870,000 |
| 5776962 |
Lactone compounds for treating patient with precancerous lesions |
Paul Gross, Rifat Pamukcu, Klaus Brendel |
1998-07-07 |
|
| 5696159 |
Lactone compounds for treating patients with precancerous lesions |
Paul Gross, Rifat Pamukcu, Klaus Brendel |
1997-12-09 |
|